Article Details
Retrieved on: 2020-01-13 23:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>... we are pleased to be collaborating with Pfizer on its target identification efforts," said Alex Zhavoronkov, PhD, founder, and CEO of <b>Insilico Medicine</b>.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here